The Global Health Body Issues Concern Over Acute Shortage of Weight-Loss Injections
Under a tenth of individuals who could benefit from weight-loss injections like Wegovy have access to them, caution the global health agency as it publishes its initial advice on the medications.
Considering over a billion individuals worldwide now obese, it is advocating for more widespread and fairer availability to this class of drugs.
Per estimates, over two billion could be obese by 2030 unless action is taken.
"Our new guidelines acknowledges that excess weight is a lifelong illness that can be addressed with thorough and continuous care," said the agency's head Tedros Adhanom Ghebreyesus.
High costs, constrained manufacturing, and distribution challenges are significant hurdles to widespread availability to the treatments that can help people shift considerable body mass, explains the organization.
GLP-1 Therapy Shortage
Despite the present best projected outlook, the manufacturing of GLP-1 therapies would only suffice for approximately 100 million people – under 10% of eligible patients, according to the health organization.
The recommendation urges nations and manufacturers to widen access, by approaches like patent sharing.
Exclusive production rights on the active ingredient – the main component of the drug Wegovy – is due to expire in several countries in 2026.
The Way Weight-Loss Drugs Function
GLP-1 drugs imitate a natural hormone to reduce digestion speed, curb appetite and increase feelings of fullness so people eat less.
People commonly see weight reduction within a few weeks of starting on the weekly injections.
Studies suggests people may put most of the weight back on after a year of discontinuing the medication, because their normal food cravings return.
To be carrying excess weight elevates your risk for contracting health problems, like diabetes, cardiovascular issues, brain attack, and specific malignancies.
Excess weight concerns individuals in countries worldwide and was associated with over three and a half million fatalities worldwide in 2024, according to the health agency.
